sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Chronic Cough Market Scope And Analysis

  • Report Code : TIPRE00013263
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 153
Buy Now

Asia Pacific Chronic Cough Market Analysis, Scope, and Growth by 2027

Buy Now

Asia Pacific Chronic Cough Market Report Asia Pacific Chronic Cough Market Size and Share Asia Pacific Chronic Cough Market Scope and Analysis

Asia Pacific Chronic Cough Market Report Scope

Report Attribute Details
Market size in 2019 US$ 1,136.66 Million
Market Size by 2027 US$ 2,155.25 Million
Global CAGR (2020 - 2027) 8.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Drug Class
  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
By Route of Administration
  • Oral
  • Injections
  • Nasal
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Bayer AG
  • Mylan N V
  • Amneal Pharmaceuticals Inc
  • Cipla Inc
  • Reckitt Benckiser Group plc
  • Sun Pharmaceutical Industries Ltd